![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Taizhou Taifa Pharmaceuticals Co., Ltd. Xianju Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Medroxyprogesterone acetate, Micronised, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2015-001 - Rev 00
This Chemical Type CEP, issued on September 12, 2017, remains in force until October 27, 2022, ensuring its reliability within the pharmaceutical industry.
Substance Number 673 associated with this CEP further emphasizes